Donna has testified before Congress and addressed the National Academies of Medicine. She's taken the stage at Aspen Ideas: Health, South by Southwest, and the Milken Future of Health Summit.
She's spoken at the Financial Times Pharma Pricing & Value Summit, BIO International, AHIP's Executive Leadership Summit, and alongside FDA leadership at the Harvard MRCT Center.
Across policy, research, and industry, her voice shows up wherever health policy, innovation, and equity intersect, and where decisions actually get made.